Dr. Surinder Singh holds a Master of Science and a PhD in Biotechnology from Jawaharlal Nehru University, India. His PhD thesis work resulted in the development of high throughput methods for the recovery of recombinant proteins from inclusion bodies in E. coli. Dr. Singh then joined the Skaggs School of Pharmacy, University of Colorado, Denver, as a post-doctoral fellow, where Dr. Singh gained expertise in biophysical characterization of therapeutic proteins. During his post-doctoral research work, Dr. Singh used high resolution techniques, i.e., hydrogen deuterium exchange in combination with 2D-NMR, to probe the residue level interactions of formulation excipients on biophysical stability of proteins. Currently Dr. Singh is working as a senior scientist, a member of biologics development group responsible for biophysical characterization, forced degradation studies, CQA assessment, comparability assessment and particulate characterization at Bristol Myers-Squibb, New Brunswick.